Cargando…
Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
BACKGROUND: The types of outcomes measured collected in clinical studies and those required for cost-effectiveness analysis often differ. Decision makers routinely use quality adjusted life years (QALYs) to compare the benefits and costs of treatments across different diseases and treatments using a...
Autores principales: | Gray, Laura A., Hernandez Alava, Monica, Wailoo, Allan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600775/ https://www.ncbi.nlm.nih.gov/pubmed/34794404 http://dx.doi.org/10.1186/s12885-021-08964-5 |
Ejemplares similares
-
Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
por: Gray, Laura A., et al.
Publicado: (2022) -
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
por: Proskorovsky, Irina, et al.
Publicado: (2014) -
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
por: Kim, Seon Ha, et al.
Publicado: (2012) -
Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma
por: Gray, Laura A., et al.
Publicado: (2018) -
Mapping EORTC-QLQ-C30 onto EQ-5D-5L Index in Indonesian Cancer Patients
por: Perwitasari, Dyah Aryani, et al.
Publicado: (2023)